Scientists test designer immune molecules in autoimmune diseases
NCT ID NCT05544448
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether specially engineered versions of a natural immune protein (IL-2) can selectively boost regulatory T cells, which help calm the immune system. Researchers took blood samples from 67 people with various autoimmune or inflammatory conditions and tested these modified proteins in the lab. The goal was to see if the proteins could activate the right cells without overstimulating the immune system, potentially leading to better treatments in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACQUIRED BONE MARROW APLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Henri Mondor, 1 rue Gustave Eiffel,
Créteil, Île-de-France Region, 94000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Can a new injection calm severe eczema when creams fall short?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can a new pill help teens regrow hair lost to alopecia?
- Can Brain-Training apps fix sleep in MS?